Total Funding
61
61
Total FundingGrant raised
Growth Score
-28 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
151685
ScitoVation is a biotechnology company that provides technical expertise and technology on pharmaceuticals and agricultural chemicals.
- Jean Orelien: CEOPast Role: Scimetrika, CEO and President
Ray Gross: Chief Operating Officer
About the Company
ScitoVation is a biotechnology company that provides technical expertise and technology on pharmaceuticals and agricultural chemicals. The company also helps clients develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products. They develop customized cell-based assays to
determine safety, model chemical disposition in the body, and analyze and interpret genetic data.
ScitoVation investigates complex issues, such as chemical modes of action, animal to human exposure extrapolation, and the use of genetic expression and sequencing data to ascertain toxicity. It was founded in 2016 and is headquartered in Durham, North Carolina, USA.
